Journal of Cancer Research and Therapeutics Close
 

Figure 3: Kaplan Meier survival analysis in pulmonary anaplastic large-cell lymphoma using log-rank test (n = 29). The median overall survival was 60 months (a) which was significantly higher among pediatric population (≤18 years) compared to adults (>18 years) (log-rank, P = 0.026) (b). There was no statistical significance in survival when correlated with ALK1 status [c], blue line; ALK1+ (, red line; ALK-), presence or absence of collapse/atelectasis (d); or effusion (e) (log-rank, P > 0.05)

Figure 3: Kaplan Meier survival analysis in pulmonary anaplastic large-cell lymphoma using log-rank test (<i>n</i> = 29). The median overall survival was 60 months (a) which was significantly higher among pediatric population (≤18 years) compared to adults (>18 years) (log-rank, <i>P</i> = 0.026) (b). There was no statistical significance in survival when correlated with ALK1 status [c], blue line; ALK1+ (, red line; ALK-), presence or absence of collapse/atelectasis (d); or effusion (e) (log-rank, <i>P</i> > 0.05)